Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02418494 · ClinicalTrials.gov registry record
Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions
A clinical trial, sponsored by AIDS Malignancy Consortium.
- Completed
- Registry status
- 85
- Enrollment target
NCT02418494: Completed study, sponsored by AIDS Malignancy Consortium.
NCT02418494 is a clinical trial that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02418494 has completed, sponsored by AIDS Malignancy Consortium.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
Study Summary
This research trial studies health-related symptom questionnaires in measuring quality of life in human immunodeficiency virus (HIV)-infected participants treated with or monitored for anal lesions. Collecting information and symptoms from patients diagnosed with anal lesions may help reduce the risk of anal cancer.
Interventions
- OTHER Concept Elicitation
- OTHER Comprehension Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-05 |
What the finished NCT02418494 record still lists
NCT02418494 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Concept Elicitation is the first listed.
NCT02418494 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02418494 about?
NCT02418494 is a clinical study titled "Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions". This research trial studies health-related symptom questionnaires in measuring quality of life in human immunodeficiency virus (HIV)-infected participants treated with or monitored for anal lesions. Collecting information and symptoms from patients diagnosed with anal lesions may help reduce the ris...
What is the current status of trial NCT02418494?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2015-04. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02418494?
The interventions under investigation include: Concept Elicitation (OTHER), Comprehension Assessment (OTHER).
Who is sponsoring clinical trial NCT02418494?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia